Robust inference in summary data Mendelian randomisation via the zero modal pleiotropy assumption by Hartwig, Fernando et al.
                          Hartwig, F., Davey Smith, G., & Bowden, J. (2017). Robust inference in
summary data Mendelian randomisation via the zero modal pleiotropy
assumption. International Journal of Epidemiology, 46(6), 1985-1998.
[dyx102]. https://doi.org/10.1093/ije/dyx102
Publisher's PDF, also known as Version of record
License (if available):
CC BY
Link to published version (if available):
10.1093/ije/dyx102
Link to publication record in Explore Bristol Research
PDF-document
University of Bristol - Explore Bristol Research
General rights
This document is made available in accordance with publisher policies. Please cite only the published
version using the reference above. Full terms of use are available:
http://www.bristol.ac.uk/pure/about/ebr-terms
Original article
Robust inference in summary data Mendelian
randomization via the zero modal pleiotropy
assumption
Fernando Pires Hartwig,1,2* George Davey Smith2,3
and Jack Bowden2,3
1Postgraduate Program in Epidemiology, Federal University of Pelotas, Pelotas, Brazil, 2MRC Integrative
Epidemiology Unit and 3School of Social and Community Medicine, University of Bristol, Bristol, UK
*Corresponding author. Postgraduate Program in Epidemiology, Federal University of Pelotas, Pelotas (Brazil) 96020-220.
E-mail: fernandophartwig@gmail.com.
Editorial decision 16 May 2017; Accepted 22 May 2017
Abstract
Background:Mendelian randomization (MR) is being increasingly used to strengthen causal
inference in observational studies. Availability of summary data of genetic associations for a
variety of phenotypes from large genome-wide association studies (GWAS) allows straight-
forward application of MR using summary data methods, typically in a two-sample design.
In addition to the conventional inverse variance weighting (IVW) method, recently developed
summary data MRmethods, such as the MR-Egger and weighted median approaches, allow
a relaxation of the instrumental variable assumptions.
Methods: Here, a new method - the mode-based estimate (MBE) - is proposed to obtain
a single causal effect estimate from multiple genetic instruments. The MBE is consistent
when the largest number of similar (identical in infinite samples) individual-instrument
causal effect estimates comes from valid instruments, even if the majority of instruments
are invalid. We evaluate the performance of the method in simulations designed to
mimic the two-sample summary data setting, and demonstrate its use by investigating
the causal effect of plasma lipid fractions and urate levels on coronary heart disease risk.
Results: The MBE presented less bias and lower type-I error rates than other methods
under the null in many situations. Its power to detect a causal effect was smaller com-
pared with the IVW and weighted median methods, but was larger than that of MR-Egger
regression, with sample size requirements typically smaller than those available from
GWAS consortia.
Conclusions: The MBE relaxes the instrumental variable assumptions, and should be
used in combination with other approaches in sensitivity analyses.
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Introduction
Using germline genetic variants as instrumental variables
of modifiable exposure phenotypes can strengthen causal
inference in observational studies by applying the prin-
ciples of Mendelian randomization (MR).1,2 This method
has already been used to address causality in several
exposure-outcome combinations and has become a com-
mon feature in the recent epidemiological literature.3
Causal inference using MR relies on the instrumental vari-
able assumptions, which require that the genetic variant is:
(i) associated with the exposure; (ii) independent of con-
founders of the exposure-outcome association; and (iii) in-
dependent of the outcome after conditioning on the
exposure and all exposure-outcome confounders.
Recent MR methods allow performing MR with mul-
tiple genetic instruments, typically single nucleotide poly-
morphisms (SNPs), using summary data estimates from
genome-wide association studies (GWAS).4 Given the
increasing number of publicly available summary statistics
from large GWAS consortia, summary data MR methods
enable many causal hypotheses to be rapidly interrogated
without the administrative burden and cooperation
required to perform equivalent individual-level data
analyses.5,6
However, using many instruments in an MR analysis in-
creases the probability of including at least one invalid in-
strument, which could easily bias the estimate. For
example, the inverse variance weighting (IVW) method re-
quires that either all variants are valid instruments or that
there is balanced horizontal pleiotropy (i.e. horizontal
pleiotropic effects of individual instruments sum to zero)
and that such pleiotropic effects are independent of instru-
ment strength across all variants (i.e. the Instrument
Strength Independent of Direct Effects – InSIDE – assump-
tion).4,7 More recently, other summary data MR methods
that allow relaxion (but not elimination) of the
instrumental variable assumptions regarding horizontal
pleiotropy have been proposed.8,9
In this paper, we describe a new summary data MR
method – the mode-based estimate (MBE). We clarify
when this will be a consistent estimate of the causal effect,
compare it with established summary data MR methods
using simulations and illustrate its application using real
data examples.
Methods
In order to motivate the summary data methods discussed in
this paper, we assume the following data-generating model
linking genetic variant Gj (j ¼ 1; . . . ;L), a continuous expos-
ure X and outcome Y for subject i:
XijGij ¼ bX0 þ bXjGij þ kXij (1)
YijGij ¼ bY0 þ bbXj þ aj
 
Gij þ kYij
¼ bY0 þ bYjGij þ kYij:
(2)
Here, bXj and bYj ¼ bbXj þ aj
 
represent Gj’s true associ-
ation with the exposure and outcome, respectively. bbXj is
the effect of Gj on Y through X, where b is the causal ef-
fect of X on Y we wish to estimate. The term aj represents
the association between Gj and Y not through the expos-
ure of interest, due to horizontal pleiotropy. The error
terms kXij and kYij will generally be correlated when col-
lected on the same individuals. However, we will mainly
focus on the two-sample setting where the error terms are
independent, because independent samples are used to fit
models (1) and (2). For simplicity, we will also assume
that all L genetic variants are mutually independent of
one another.
Let b^Xj and b^Yj represent the SNP-exposure and SNP-
outcome association estimates for variant j, respectively,
Key Messages
• Summary data Mendelian randomization, typically in a two-sample setting, is being increasingly used due to the
availability of summary association results from large genome-wide association studies.
• Mendelian randomization analyses using multiple genetic instruments are prone to bias due to horizontal pleiotropy,
especially when genetic instruments are selected based solely on statistical criteria.
• A causal effect estimate robust to horizontal pleiotropy can be obtained using the mode-based estimate (MBE).
• The MBE requires that the most common causal effect estimate is a consistent estimate of the true causal effect,
even if the majority of instruments are invalid (i.e. the ZEro Modal Pleiotropy Assumption, or ZEMPA).
• Plotting the smoothed empirical density function is useful to explore the distribution of causal effect estimates, and
to understand how the MBE is determined.
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and let r2Xj and r
2
Yj represent the variance of b^Xj and b^Yj, re-
spectively. The ratio estimate10,11 for the causal effect b
using variant j alone is equal to:
b^Rj ¼
b^Yj
b^Xj
(3)
the standard error of which (rRj) can be obtained using the
delta method12 as follows:
rRj ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
r2Yj
b^
2
Xj
þ b^
2
Yjr
2
Xj
b^
4
Xj
vuut (4)
The standard error in (4) can be simplified to rYj=jb^Xjj
when the variance of the SNP-exposure association r2Xj is
small enough to be considered ‘ignorable’, or equivalently
that b^Xj ¼ bXj . This is referred to as the NO
Measurement Error (NOME) assumption.13
The ratio estimate b^Rj is a crude measure of causal ef-
fect, but has a major advantage over more sophisticated
methods in that it can be calculated using summary data
estimates for bXj and bYj alone. These estimates can then
be used to furnish a summary data MR analysis using the
framework of a meta-analysis.
Under models (1) and (2), variant j is a valid instrument
when aj¼ 0 and invalid when aj 6¼ 0. When aj 6¼ 0, then
bRj ¼ bþ bj, where bj ¼ aj=bXj (i.e. a bias term). In the
Supplementary Methods (available as Supplementary data
at IJE online), we briefly review three such summary data
methods – IVW,4 MR-Egger regression8 and weighted me-
dian9 – and discuss the conditions under which each
method returns a consistent causal effect estimate (i.e. esti-
mate converges in probability to the true value as the sam-
ple size increases).
The MBE
In this paper we propose a new causal effect estimator –
the MBE – that offers robustness to horizontal pleiotropy
in a different manner to that of the IVW, MR-Egger or
weighted median methods. Its ability to consistently esti-
mate the true causal effect relies on the following funda-
mental assumption termed the ZEro Modal Pleiotropy
Assumption (ZEMPA): across all instruments, the most
frequent value (i.e., the mode) of bj is 0.
In order to formalize this, let k 2 f1;2; . . . ;Lg represent
the number of unique values of bj among the L variants. If
all bj terms are identical then k¼ 1, but if all are unique
then k ¼ L. Now, let n1; n2; . . . ;nk represent the number of
instruments that have the same non-zero value of bj, where
n1 represents those with the smallest non-zero identical
value of bj and nk represents those with the largest non-zero
identical value. Finally, let n0 represent the number of valid
instruments whose bj terms are identically zero. We then
have that n0 þ n1 þ . . .þ nk ¼ L. ZEMPA implies that n0 is
larger than any other nl for l in 1;2; . . . ;k (i.e.,
n0 > maxðn1; . . . ; nkÞ). For a weighted version of the MBE,
that is an MBE derived by allowing the weight given to each
ratio estimate to vary, ZEMPA implies that the weights
associated with the valid instruments are the largest among
all k subsets of instruments (ie. w0 > maxðw1; . . . ;wkÞ,
where wl is the weight contributed by the lth subset of in-
struments using our previous subset definition based on bj.
The breakdown level (i.e. the maximum proportion of
information that can come from invalid instruments before
the method is inconsistent) of the simple (i.e. unweighted)
MBE ranges from 100 L=2þ1L
 
% to 100 L2L
 
%. The lower
limit corresponds to the situation where there are some
valid instruments, but all invalid instruments estimate the
same (biased) causal effect parameter (i.e. k ¼ 2) implying
that ZEMPA is satisfied (i.e. n0 > maxðn1; . . . ;nkÞ) if up
to, but not including, half of the instruments are invalid.
The upper limit corresponds to the situation where all in-
valid instruments estimate different causal effect param-
eters (i.e. n1 ¼ n2 ¼ . . . ¼ nk ¼ 1), implying that ZEMPA
would be satisfied if just two variants were valid (n0 ¼ 2Þ and
the remainder (L 2) were invalid. Given that maxðn1; . . . ;
nkÞ is often unknown and is likely to vary depending on the
set of genetic instruments and the outcome variable, the true
breakdown level of the MBE in any given applied investiga-
tion is difficult to determine.
For example, in Figure 1A, six out of eight instruments
are invalid (so n0 ¼ 2), but all non-zero bjs are unique,
implying that k ¼ L 1 ¼ 7 and n1 ¼ n2 ¼ . . . ¼ n7 ¼ 1.
In this situation, ZEMPA is satisfied and the simple MBE is
a consistent estimate of the causal effect b. However, when
the largest number of identical estimates comes from invalid
instruments (i.e. n0 < nl for some l; ZEMPA violated),
then the simple MBE will be inconsistent for b (i.e. asymp-
totically biased). This is illustrated in Figure 1B, which
shows causal effect estimates from six invalid and two valid
variants (n0 ¼ 2). Since three variants have precisely the
same horizontal pleiotropic effect in this example (n2 ¼ 3),
ZEMPA is violated.
The breakdown level of the weighted MBE can be simi-
larly defined as ranging from 50% (exclusive) to 100%
(exclusive). In other words, the weighted MBE is biased if
w0 < wl for some l. Of note, the limits are open intervals
because the weights are real numbers, unlike number of in-
struments (in the case of the simple MBE), which is a nat-
ural number. However, as L increases, then the lower and
upper limits of the breakdown level of the simple MBE
also tend to 50% and 100%, respectively.
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Implementing the MBE
To calculate the MBE, we propose using the mode of the
smoothed empirical density function of all b^Rjs as the
causal effect estimate. This strategy is straightforward to
implement, easily deals with sampling variation in asymp-
totically identical b^Rjs and allows different weights to be
given to different instruments. We refer to the mode of the
unweighted and inverse-variance weighted empirical dens-
ity function as the simple and weighted MBEs, respect-
ively. The standardized weights for the weighted MBE can
be computed as follows:
wj ¼ r2Rj =
XL
j¼1
r2Rj (5)
For the simple MBE, w1 ¼ w2 ¼ . . . ¼ wL ¼ 1=L.
Consider the normal kernel density function of the b^Rjs:
f ðxÞ ¼ 1
h
ﬃﬃﬃﬃﬃ
2p
p
XL
j¼1
wjexp  1
2
x b^Rj
h
 !224
3
5 (6)
where h is the smoothing bandwidth parameter.14 The
causal effect estimate obtained using the MBE method b^M
is the value of x that maximizes f ðxÞ (i.e.
f ðb^MÞ ¼ max½f ðxÞ). The h parameter regulates a bias-
variance trade-off of the MBE, with increasing h leading to
higher precision, but also to higher bias. Here, h ¼ us,
with u being a tuning parameter that allows increasing or
decreasing the bandwidth, and s being the default band-
width value chosen according to some criterion. We used
the modified Silverman’s bandwidth rule proposed by
Bickel15:
s ¼
0:9min

sd b^RJ
 
; 1:4826mad b^RJ
 
L
1
5
(7)
where sdðb^RJÞ and mad b^RJ
 
are the standard deviation
and median absolute deviation from the median of the L
b^Rjs, respectively. An intuitive explanation of the MBE
based on an analogy with histograms is provided in the
Supplementary Methods (available as Supplementary data
at IJE online).
Simulation model
The simulations were performed using the following model
to generate individual i’s exposure Xi, outcome Yi and con-
founder Ui, based on their underlying genetic data vector
(Gi1; . . . ;GiL):
Ui ¼ cUZUi þ eUi (8)
Xi ¼ cXZXi þ hXUi þ eXi (9)
Yi ¼ cYZYi þ bXi þ hYUi þ eYi (10)
where:
ZUi ¼
XL
j¼1
dUjGij

=rZU; ZXi ¼
XL
j¼1
dXjGij

=rZX;
ZYi ¼
XL
j¼1
dYjGij

=rZY :
ZU, ZX and ZY represent the additive allele scores of L in-
dependent SNPs on U, X and Y, modulated by the param-
eters dUj; dXj; dYj (j¼ 1,. . . L). b denotes the true causal
effect of X on Y that we wish to estimate. The underlying
Figure 1. Illustration of the ZEro Modal Pleiotropy Assumption (ZEMPA) in the simple (i.e. unweighted) mode-based estimate (MBE). bM is the simple
MBE causal effect and b is the true causal effect; nl denotes the number of variants with a given horizontal pleiotropic effect (n0 denotes the number
of valid instruments). Panel A: ZEMPA is satisfied. Panel B: ZEMPA is violated. SNP, single nucleotide polymorphism.
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genetic variables (Gij) were generated independently by
sampling from a Binomial (2, p) distribution with p itself
drawn from a Uniform(0.1,0.9) distribution, to mimic bi-
allelic SNPs in Hardy-Weinberg equilibrium. The resulting
allele scores were then divided by their sample standard de-
viations rZU; rZX; rZYð ), to set variances to one. The dir-
ect effects of U on X and Y are denoted by hX and hY ,
respectively. hX and hY are set to positive values in all
simulations, so as to always induce positive confounding.
Error terms eUi; eXi; eYi were independently generated
from a normal distribution, with mean¼ 0 and variances
r2eU, r
2
eX and r
2
eY , respectively, whose values were chosen
to set the variances of U, X and Y to one.
Constraining the variances in this way enables easy
interpretation of the parameters in models (8)–(10). For
example, b¼ 0.1 implies that one standard deviation
increment in X causes a 0.1 standard deviation increment
in Y, and that the causal effect of X on Y explains
0.12¼ 1% of Y variance. A summary data interpret-
ation of our simulation model is provided in the
Supplementary Methods (available as Supplementary
data at IJE online).
Simulation scenarios
Although the consistency property of an estimator provides
a formal justification of the approach, it is equally import-
ant to understand how well it works in practice for realis-
tically sized datasets in comparison with other methods.
Therefore, we evaluated our proposed estimator in four
different simulation scenarios. In all simulations, the num-
ber of variants L¼30, hX ¼ hY ¼
ﬃﬃﬃﬃﬃﬃﬃ
0:3
p
, cX ¼
ﬃﬃﬃﬃﬃﬃﬃ
0:1
p
and cU ¼ cY ¼ q
ﬃﬃﬃﬃﬃﬃﬃ
0:1
p
=L, where q ¼ 0; 3; 6; . . . ;30 is
the number of invalid instruments.
Simulations 1 and 2 were aimed at evaluating the
performance of the MBE under the causal null (b¼ 0) in
the two-sample setting. Datasets of 100 000 individ-
uals were simulated and divided in half at random,
and each was used to estimate either SNP-exposure or
SNP-outcome associations. Simulations 3 and 4 were
aimed at evaluating weak instrument bias in the two-
sample and single-sample settings; sample sizes used to
estimate instrument-exposure (NX) and instrument-
outcome (NY) associations were allowed to vary, as
described below.
Simulation 1. In this scenario, dUj was 0 for all instru-
ments, implying that there is no InSIDE-violating horizon-
tal pleiotropy. InSIDE-respecting horizontal pleiotropic
effects dYj were drawn from a Uniform(0.01, 0.2) distribu-
tion for the q invalid instruments or were set to 0 for valid
instruments. Given that b¼ 0, power can be interpreted as
the type-I error rate.
Simulation 2. InSIDE-violating horizontal pleiotropy was
induced by setting dYj¼ 0 for all instruments, whereas dUj
values were drawn from a Uniform(0.01, 0.2) distribution
for the q invalid instruments.
Simulation 3. This simulation evaluated the performance
of the estimators to detect a positive causal effect of
b¼ 0.1 in the two-sample context. q¼ 0, implying that
there is no horizontal pleiotropy, and NX 2 {25 000,
50 000, 100 000}, and NY 2 {25 000, 50 000, 100 000}.
Simulation 4. This simulation evaluated the performance
of the estimators under the causal null when SNP-exposure
and SNP-outcome associations are estimated in partially
(50%) or fully (100%) overlapping samples (the latter
being equivalent to the single sample setting). It was imple-
mented as for simulation 3, except b¼0 and NX ¼ NY 2
{1 000, 5 000, 10 000}. We used smaller sample sizes to
purposely increase the bias due to sample overlap, thus
facilitating comparisons between methods.
Applied examples: plasma lipid fractions and
urate levels and coronary heart disease risk
Do and colleagues16 performed a two-sample MR analysis
to evaluate the causal effect of low-density lipoprotein cho-
lesterol (LDL-C), high-density lipoprotein cholesterol
(HDL-C) and triglycerides on coronary heart disease
(CHD) risk, using a total of 185 genetics variants.
Summary association results were obtained from the
Global Lipids Genetics Consortium17 and the Coronary
Artery Disease Genome-Wide Replication and Meta-
Analysis Consortium,18 and were downloaded from Do
and colleagues’ supplementary material (standard errors
were estimated based on the regression coefficients and
P-values). Genetic variants were classified as instruments
for each lipid fraction using a statistical criterion
(P< 1 108), resulting in 73 instruments for LDL-C, 85
for HDL-C and 31 for triglycerides.
White and colleagues19 performed a similar analysis,
but with plasma urate levels rather than lipid fractions. 31
variants associated with urate levels (P< 5 107) were
used as genetic instruments, and the required summary sta-
tistics were obtained from the GWAS catalogue [https://
www.ebi.ac.uk/gwas/].
Statistical analyses
In all simulation scenarios, causal effect estimates were
obtained using established MR methods (multiplicative
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random effects IVW,7 multiplicative random effects MR-
Egger regression7 and weighted median, all implemented
using inverse-variance weights calculated under NOME),
as well as the simple and the weighted MBEs. Each version
of the MBE was evaluated using weights calculated with
and without making the NOME assumption, thus yielding
four MBEs. Each of these four methods was evaluated for
two values of the tuning parameter u 2 f1;0:5g, totalling
eight versions of the MBE method. Parametric
bootstrap was used to estimate the standard errors of the
MBE using the median absolute deviation from the median
(multiplied by 1.4826 for asymptotically normal consis-
tency) of the bootstrap distribution of causal effect esti-
mates. These were used to derive symmetrical confidence
intervals.
In each scenario, coverage, power and average causal
effect estimates, standard errors, FGX1
FGX
and I2GX statistics
(which quantify the magnitude of violation of the NOME
assumption in IVW and MR-Egger regression estimates,
respectively7,13) were obtained across 10 000 simulated
datasets. Power was defined as the proportion of times that
95% confidence intervals excluded zero, and coverage as
the proportion of times that 95% confidence intervals
included the true causal effect.
MR methods were also applied to estimate the causal
effect of plasma lipid fractions and urate levels on CHD
risk. The magnitude of regression dilution bias in IVW and
MR-Egger regression was assessed by the FGX1
FGX
and I2GX
statistics, respectively. Cochran’s Q test was used to test
for the presence of horizontal pleiotropy (under the
assumption that this is the only source of heterogeneity
between b^Rjs other than chance).
20 All simulations and
analyses were performed using R 3.3.1 [www.r-project.
org]. R code for implementing the MBE is provided in
Supplementary Methods (available as Supplementary data
at IJE online).
Results
Performance under the causal null in the two-
sample context
The results of simulation 1 – where directional horizontal
pleiotropy (if any) occurs only under the InSIDE assump-
tion – are shown in Table 1. When all instruments were
valid, all methods were unbiased with type-I error rates 
5%. As expected, MR-Egger regression (which is consis-
tent if InSIDE holds) was the least biased method in this
scenario, especially when many instruments were invalid.
The four MBEs in Table 1 were less biased and less precise
than the IVW and the weighted median methods. The sim-
ple MBE was more biased than the weighted MBE
(noticeable especially when the proportion of invalid
instruments was high). Using weights derived under the
NOME assumption increased bias and false rejection rates.
Setting u¼0.5 (i.e. setting the bandwidth to half of the
default value) reduced both bias and precision
(Supplementary Table 1, available as Supplementary data
at IJE online).
When InSIDE is violated (Table 2), again the MBEs
were less biased than IVW and weighted median methods.
In this case, however, they were also less biased than MR-
Egger regression estimates, which is known to be highly
sensitive to InSIDE violation.8 The exception was for large
proportions (i.e.  80%) of invalid instruments, where
MR-Egger estimates were the least biased. This is because
the degree of InSIDE violation, as quantified by the
inverse-variance weighted Pearson correlation between
instrument strength and horizontal pleiotropic effects,8 is
smaller in those situations (Supplementary Table 2, avail-
able as Supplementary data at IJE online). Moreover, in
this scenario, the simple MBE was generally less biased
than the weighted counterparts, and setting u¼0.5 had a
smaller effect when compared with simulation 1 (and
indeed only clear for the simple MBE–Supplementary
Table 3). The NOME assumption again increased bias and
false rejection rates.
Power to detect a causal effect in the two-sample
context
Table 3 displays the results for simulation 3 (no invalid
instruments). The IVW method was the most powered to
detect a causal effect, followed by the weighted median
method, the weighted MBE, the simple MBE and MR-
Egger regression. Assuming NOME reduced the bias
towards the null in the weighted MBEs and improved
power. Setting u¼ 0.5 had no consistent effect on bias, but
substantially reduced power (Supplementary Table 4,
available as Supplementary data at IJE online).
Performance under the causal null in overlapping
samples
Supplementary Table 5 (available as Supplementary data
at IJE online) displays the performance of the methods
under the causal null when the samples used to estimate
instrument-exposure and instrument-outcome associations
overlap. MR-Egger regression presented the largest bias,
followed by the weighted MBE assuming NOME,
the weighted MBE not assuming NOME, weighted
median, simple MBE and IVW. Setting u¼0.5 slightly
increased the bias (Supplementary Table 6, available as
Supplementary data at IJE online). Importantly, the
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precision of the MBE was very low, suggesting that the
method may be prohibitively underpowered in small sam-
ples, thus being best suited for the two-sample setting using
precise summary association results. Gains in precision by
making the NOME assumption were more noticeable than
in the other simulations with larger sample sizes.
Causal effect of plasma lipid fractions and urate
levels on CHD risk
We used real datasets of summary association results to
further explore the influence of the u parameter on the
MBE. First, we visually explored the distribution of ratio
estimates (Figure 2). In the case of LDL-C (panel A), most
of the distribution was above zero, and increasing the
stringency of u did not reveal substantial multimodality,
although there were some pronounced density peaks at the
left of the main distribution (which corresponds to the true
causal effect under the ZEMPA assumption), which may
result in attenuation of the causal effect estimate.
However, setting u¼0.25 resulted in some small peaks in
the main distribution which may suggest over-stringency,
so we used u¼ 0.5 in the MR analysis. For HDL-C (panel
B), the bulk of the distribution was centred close to zero,
and setting u¼ 0.25 revealed some peaks at the left of the
main distribution, suggesting that horizontal pleiotropy
could lead to an apparent protective effect. Since setting
u¼0.5 was sufficient to substantially reduce the density at
the tails, this was used in the MR analysis. Regarding tri-
glycerides (panel C), the main distribution was above zero
Table 3. Mean estimates from simulation 3: no horizontal pleiotropy and causal effect b¼0.1 (10 000 simulations per scenario).
Sample sizes NX and NY are in thousands
Estimator Statistic N Mean FGX1
FGX
[%]; mean I2GX [%]
99.3; 94.8 99.3; 94.8 99.3; 94.8 99.7; 97.4 99.7; 97.4 99.7; 97.4 99.8; 98.7 99.8; 98.7 99.8; 98.7
NX 25 25 25 50 50 50 100 100 100
NY 25 50 100 25 50 100 25 50 100
IVW Beta 0.099 0.099 0.099 0.099 0.099 0.100 0.100 0.100 0.100
SE 0.021 0.015 0.011 0.021 0.015 0.011 0.021 0.015 0.010
Coverage (%) 96.5 96.5 96.4 96.7 96.3 96.7 96.1 96.7 97.0
Power (%) 99.8 100.0 100.0 99.8 100.0 100.0 99.7 100.0 100.0
MR-Egger Beta 0.096 0.096 0.096 0.098 0.098 0.098 0.099 0.099 0.099
SE 0.045 0.032 0.023 0.046 0.032 0.023 0.046 0.033 0.023
Coverage (%) 96.7 96.2 96.2 96.8 96.5 96.5 96.1 96.8 96.6
Power (%) 53.7 82.1 97.8 54.2 84.0 98.1 54.9 83.9 98.5
Weighted Beta 0.099 0.098 0.098 0.099 0.099 0.099 0.100 0.099 0.100
Median SE 0.029 0.020 0.015 0.029 0.020 0.014 0.029 0.020 0.014
Coverage (%) 97.3 97.1 97.1 97.1 97.2 97.4 97.0 97.4 97.9
Power (%) 95.3 100.0 100.0 95.5 100.0 100.0 95.2 100.0 100.0
Simple Beta 0.099 0.098 0.099 0.099 0.099 0.100 0.100 0.099 0.100
MBEa SE 0.087 0.061 0.047 0.073 0.045 0.035 0.053 0.037 0.027
Coverage (%) 99.0 99.1 98.9 99.1 99.0 99.1 98.8 98.8 99.2
Power (%) 59.4 85.7 94.1 61.3 88.6 96.9 64.0 91.0 98.2
Weighted Beta 0.097 0.097 0.097 0.098 0.098 0.099 0.099 0.098 0.099
MBEa SE 0.079 0.055 0.043 0.065 0.040 0.031 0.044 0.031 0.022
Coverage (%) 98.4 98.4 98.2 98.3 98.1 98.2 98.0 98.3 98.4
Power (%) 75.2 90.9 94.7 77.5 94.5 97.1 80.0 96.7 98.7
Simple Beta 0.099 0.098 0.099 0.099 0.099 0.100 0.100 0.099 0.100
MBE SE 0.047 0.033 0.023 0.046 0.032 0.023 0.045 0.033 0.023
(under Coverage (%) 98.8 98.9 98.8 99.1 98.9 99.0 98.8 98.9 99.1
NOME)a Power (%) 64.1 91.1 98.8 64.2 91.4 99.2 64.9 91.7 99.3
Weighted Beta 0.099 0.098 0.098 0.099 0.099 0.099 0.100 0.099 0.100
MBE SE 0.038 0.027 0.019 0.038 0.026 0.019 0.037 0.026 0.018
(under Coverage (%) 98.1 98.0 97.9 98.1 97.9 98.0 97.9 98.3 98.3
NOME)a Power (%) 81.5 96.6 99.3 81.0 97.2 99.5 81.5 97.6 99.8
NX; sample size of the dataset used to estimate instrument-exposure associations; NY ; sample size of the dataset used to estimate instrument-outcome associa-
tions; IVW, inverse-variance weighting; SE, estimated standard error; NOME, NO Measurement Error; MBE, mode-based estimate.
au¼ 1.
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and the plot suggested that there may be negative horizon-
tal pleiotropy, leading to an underestimation of the causal
effect (u¼ 0.25 was used in MR analysis). Finally, in the
case of urate levels (panel D), by decreasing u it became
increasingly evident that the distribution was bi-modal,
which could only be clearly distinguished by setting
u¼0.25 (which was used in MR analysis) because the
main peaks were similar to one another. Comparing the
two distributions, the main one was the closest to zero,
suggesting that horizontal pleiotropy is biasing the causal
effect estimate upwards.
Results of the MR analysis are shown in Table 4. The
smallest values of FGX1
FGX
and I2GX were 0.996 and 0.993,
respectively, suggesting that IVW and MR-Egger regres-
sion estimates were not materially affected by regression
dilution bias. P-values of the Cochran’s Q test ranged from
0.0003 (urate) to 1.7 1021 (HDL-C), thus providing
strong statistical evidence for heterogeneity between the
ratio estimates. Nevertheless, results for LDL-C and
triglycerides consistently suggested risk-increasing causal
effects. In the case of HDL-C, the IVW method suggested a
protective effect, with one standard deviation increase in
HDL-C being associated with a 0.254 (95% CI: 0.115;
0.393) decrease in CHD ln(odds). However, the other
methods did not confirm this result, suggesting that it was
due to negative horizontal pleiotropy (as suggested by visu-
ally inspecting the distribution of ratio estimates). Finally,
the IVW method suggested a 0.163 (95% CI: 0.027;
0.298) increase in CHD ln(odds) per standard deviation
increase in urate levels. Other methods did not confirm
this finding, suggesting that it could be a result of positive
horizontal pleiotropy (as the empirical density plot
suggested).
Discussion
We have proposed a new MR method – the MBE – for
causal effect estimation using summary data of multiple
Figure 2. Weighteda empirical density function of all individual-instrument ratio causal effect estimates (b^R j ) of plasma LDL-C (panel A), HDL-C (panel
B), triglycerides (panel C) and urate (panel D) levels on ln(odds ratio) of coronary heart disease for different values of the tuning parameter u. LDL-C,
low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol. The dashed line indicates the zero value. aWeights were calculated
without making the NOME assumption.
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genetic instruments. Its performance was evaluated in a
simulation study and its application illustrated in real data
examples. An overview of the summary data MR methods
that we evaluated (as well as the simple median) is pro-
vided in Table 5.
Consistent causal effect estimation using the MBE
requires that ZEMPA holds. ZEMPA is an assumption
that relates to the underlying bias parameters (the bj) that
contribute to the ratio estimand bj ¼ bþ bj identified by
the jth genetic instrument. If ZEMPA is satisfied, then the
MBE yields a consistent estimate for the causal effect.
However, due to imprecision in the b^j’s in finite samples,
in practice the MBE may be contaminated by some invalid
invariants even if ZEMPA holds. This can be seen in our
simulations, where ZEMPA is only violated when all
instruments are invalid, but nevertheless there is bias in the
MBE when some of the instruments are valid. In practice,
the MBE also depends on the magnitude of the bias, with
invalid genetic instruments identifying causal effect param-
eters that are close to the true causal effect being more
likely to contaminate the MBE estimate. However, this
also means that genetic instruments that would introduce
strong bias are less likely to contaminate the MBE.
In our simulations, we evaluated eight different versions
of the MBE. Decreasing the tuning parameter u reduced
bias (at the cost of reduced precision) when horizontal plei-
otropy did not violate the InSIDE assumption. However,
when InSIDE was violated, a similar behaviour could only
be clearly seen for the simple MBE. Choosing the value of
the tuning parameter u is a bias-variance trade-off and
depends on how stringent the smoothing bandwidth needs
to be and how stringent it can be before being prohibitively
imprecise. In our applied example, we identified the strin-
gency required through a graphical examination, and veri-
fied that the MBEs were powered enough to detect a
causal effect between HDL-C and triglycerides on CHD
risk. Moreover, in the case of urate levels, the weighted
MBE was similarly precise to the IVW and weighted
median methods. This suggests that it may be feasible to
set u to stringent values in practice, especially when there
are multiple instruments selected based on genome-wide
significance. Evaluating a range of u values through a
Table 4. Mendelian randomization estimates of the causal effect of urate plasma levels (in standard deviation units) on CHD risk
[in ln(odds)] using 31 genetic instruments
Exposure Estimator Beta SE 95% CI P-value
LDL-C IVW 0.476 0.060 0.357; 0.595 1.81011
MR-Egger b0 0.009 0.005 0.020; 0.001 0.083
MR-Egger b1 0.624 0.103 0.419; 0.828 5.3108
Weighted median 0.457 0.064 0.331; 0.583 7.41010
Simple MBEa 0.422 0.187 0.056; 0.788 0.027
Weighted MBEa,b 0.491 0.109 0.276; 0.705 2.7105
HDL-C IVW 0.254 0.070 0.393; -0.115 4.9104
MR-Egger b0 0.014 0.005 0.025; -0.003 0.011
MR-Egger - b1 0.013 0.115 0.241; 0.215 0.913
Weighted median 0.069 0.068 0.202; 0.065 0.314
Simple MBEa 0.174 0.171 0.509; 0.161 0.311
Weighted MBEa,b 0.003 0.088 0.175; 0.170 0.974
Triglycerides IVW 0.416 0.081 0.252; 0.580 6.0106
MR-Egger - b0 0.000 0.007 0.015; 0.015 0.962
MR-Egger - b1 0.422 0.140 0.140; 0.704 0.004
Weighted median 0.516 0.083 0.352; 0.679 1.5107
Simple MBEc 0.875 0.259 0.367; 1.383 0.002
Weighted MBEc,b 0.547 0.134 0.284; 0.810 1.8104
Urate levels IVW 0.163 0.066 0.027; 0.298 0.020
MR-Egger - b0 0.008 0.005 0.002; 0.018 0.118
MR-Egger - b1 0.048 0.096 0.148; 0.245 0.614
Weighted median 0.119 0.061 0.001; 0.239 0.061
Simple MBEc 0.188 0.163 0.132; 0.507 0.259
Weighted MBEc,b 0.092 0.066 0.038; 0.221 0.175
LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; IVW, inverse-variance weighting; SE, standard error; CI, confidence
interval; MBE, mode-based estimate.
au¼ 0.5.
bNot under the NO Measurement Error (NOME) assumption.
cu¼ 0.25.
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graphical examination may be useful to investigate how
susceptible the MBE is to contamination from invalid
instruments.
Assuming NOME increased bias and reduced the cover-
age of the 95% confidence intervals in the presence of
invalid instruments, but reduced regression dilution bias
and improved power in the two-sample setting. However,
such gains were relatively small and virtually disappeared
in simulations with larger sample sizes. Moreover, the
results in the applied example were virtually identical
whether or not NOME was assumed. These findings sug-
gest that the NOME assumption is not necessary (and
might be even unwarranted) when deriving weights for the
MBE.
Although the simple MBE was less precise than the
weighted MBE, it was less prone to bias due to violations
of the InSIDE assumption. However, it was more prone to
bias when InSIDE held. Indeed, a similar pattern has been
previously shown for the simple and weighted median.9
This suggests that comparing both methods would be a
useful sensitivity analysis in practice, although care must
be taken since the simple MBE may in some cases (as in
our real data example with urate levels) be prohibitively
imprecise. Importantly, all the recommendations above are
general, and we strongly encourage researchers to consider
study-specific factors when deciding upon these aspects.
One way of doing so is to perform simulations that reflect
the study-specific context and compare different thresholds
and filters in a range of different scenarios, keeping observ-
able parameters (e.g. sample size) constant. Such simula-
tions would also be useful to identify how strong the
violations of the assumptions must be in order to obtain
the observed results, which may be a useful sensitivity anal-
ysis that will either strengthen or weaken causal inference.
In our simulations, the 95% confidence intervals of the
MBE computed using the normal approximation presented
over-coverage (i.e. coverage larger than 95%). This may be
due to the MBE being less influenced by outlying instruments
(which is indeed the basis of the method), which correspond
to the most imprecise ones when all instruments are valid.
Therefore, the causal effect estimate fluctuates less around
the true causal effect b (i.e. is less influenced by sampling var-
iation). This may also explain the less pronounced over-
coverage in the weighted median. We compared the normal
approximation with the percentile method (Supplementary
Table 7, available as Supplementary data at IJE online), but
over-coverage in the latter was even greater when there were
no or few invalid instruments. Moreover, after a certain pro-
portion of invalid instruments (around 50%), coverage of the
percentile method reduced markedly, whereas this occurred
gradually in the normal approximation method. We therefore
proposed the latter method to compute confidence intervals,
but there might be better alternatives.
Another aspect of the MBE method (and of the
weighted median) that requires further research is regres-
sion dilution bias in the two-sample setting. Understanding
how regression dilution bias operates in IVW and MR-
Egger contributed to developing correction methods,13
thus reinforcing the importance of research in this area
regarding the MBE and the weighted median.
Although this is the first description of using the MBE
as a causal effect estimate in MR, other closely related
Table 5. Breakdown level and assumptions regarding horizontal pleiotropy of the inverse variance weighted (IVW), MR-Egger
regression, simple and weighted median, and simple and weighted MBEs
Method Breakdown level Assumptions regarding horizontal pleiotropy
IVW 0% Consistent if the sum of horizontal pleiotropic effects of all
instruments is zero and InSIDE holds
MR-Egger regression 100% Consistent even if all instruments are invalid if InSIDE
holds
Simple median 100 L=2þ1L
 
% Consistent if less than 50% of instruments are invalid,
regardless of the type of horizontal pleiotropy
Weighted median 50% (exclusive) Consistent if less than 50% of the weight is contributed by
invalid instruments, regardless of the type of horizontal
pleiotropy
Simple MBE Ranges from 100 L=2þ1L
 
% to 100 L2L
 
% Consistent if the most common horizontal pleiotropy value
is zero (i.e. ZEMPA), regardless of the type of horizontal
pleiotropy
Weighted MBE Ranges from 50% (exclusive) to 100% (exclusive) Consistent if the largest weights among the k subsets are
contributed by valid instruments (i.e. ZEMPA), regard-
less of the type of horizontal pleiotropy
IVW, inverse-variance weighting; InSIDE, Instrument Strength Independent of Direct Effect; ZEMPA, ZEro Mode Pleiotropy Assumption; MBE, mode-based
estimate.
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methods have already been published. For example, Guo
et al.21 have recently described a method based on bivari-
ate comparisons of all pairs of instruments, which classify
instruments as estimating or not estimating the same causal
effect. The largest identified set of concordant instruments
can then be used to estimate the causal effect using, for
example, the IVW method. Therefore, Guo et al.’s
approach also relies on the assumption that the most com-
mon causal effect estimate is a consistent estimate of the
true causal effect (i.e. ZEMPA). In fact, both our approach
and Guo et al.’s can be viewed as methods that fully
exploit the power of the consistency criterion defined origi-
nally by Kang et al,22 who used it to propose a LASSO-
based variable selection procedure to detects and adjusts
for horizontally pleiotropic variants. However, Guo et al.’s
method and the MBE (which was developed independently
from their work) are very different in their implementa-
tion. Ours is designed to be simple to understand and
implement, does not require selecting instruments, and is
easy to extend to any weighting scheme one desires.
Moreover, plotting the empirical density function using
different bandwidths may be a useful tool to visually
explore the distribution of the b^Rjs, and provides an intui-
tive way to select the optimal bandwidth value. In separate
work we conduct a thorough review Guo et al.’s method
after translating it to the two-sample context, and suggest
some simple modifications to improve its performance.23
It is also important to consider that there are other strat-
egies to compute the mode of continuous data. In prelimi-
nary simulations, the modified Silverman’s rule was both
generally more robust against horizontal pleiotropy than the
original Silverman’s rule24 and more powered to detect a
causal effect. Therefore, we opted for the modified rule.
However, many other kernels and bandwidth selection rules
could be used, as well as strategies that are not based on the
smoothed empirical density function, such as the simple and
robust parametric estimators,15 Grenander’s estimators25
and the half-sample mode method.14 Further research is
required to translate these mode estimators into the sum-
mary data MR context and compare their performance
under different scenarios.
We propose the MBE as an additional MR method
that should be used in combination with other approaches
in a sensitivity analysis framework. Using several methods
that make different assumptions, rather than a single
method, is a useful strategy to assess the robustness of the
results against violations of the instrumental variable
assumptions.26,27 Further developments in this area
(including some aspects of the MBE itself) will contribute
to expanding the arsenal of tools available to applied
researchers to interrogate causal hypotheses with observa-
tional data.
Supplementary Data
Supplementary data are available at IJE online.
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